Concepedia

David Chang

DC

72

Publications

17.5K

Citations

42

H-Index

1982

Active since

Affiliations

University of California, Los Angeles(Current)

Stanford University

Chenomx (Canada)

University of Alberta

Yale University

David Chang is an author at University of California, Los Angeles specializing in medicine, gene expression, and molecular biology.

ORCID

Top concepts

Publications per year

1982–2023

72

Publications

72

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett et al. · New England Journal of Medicine · 2017 · 5.7K citations · Full text

Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer

Rafael G. Amado, Michael Wolf, Marc Peeters et al. · Journal of Clinical Oncology · 2008 · 3.1K citations · Full text

Inhibition of Stat1-mediated gene activation by PIAS1

Bin Liu, Jiayu Liao, Xiaoping Rao et al. · Proceedings of the National Academy of Sciences · 1998 · 757 citations · Full text

, , +14

Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

Lindsay Gillan, Daniela Matei, David A. Fishman et al. · PubMed · 2002 · 563 citations

, , +16

Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting

Karsten Suhre, Christa Meisinger, Angela Döring et al. · PLoS ONE · 2010 · 558 citations · Full text

Rows per page

1–5 of 72